AmCad BioMed Intangible Assets

AmCad BioMed (4188.TWO) currently reports a intangible assets of $26M as of June 2026. That compares with $32M in the prior-year period — down 19.9% year over year. Use the charts on this page to explore AmCad BioMed's intangible assets history and peer comparisons.

AmCad BioMed's intangible assets decreased from $32M to $26M — a 19.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AmCad BioMed reported $26M in intangible assets as of June 2026. That compares with $32M in the prior-year period — down 19.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AmCad BioMed, and consider following 4188.TWO for alerts when major investors trade the stock.